BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12894593)

  • 1. Ets-2 interacts with co-repressor BS69 to repress target gene expression.
    Wei G; Schaffner AE; Baker KM; Mansky KC; Ostrowski MC
    Anticancer Res; 2003; 23(3A):2173-8. PubMed ID: 12894593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction and the Ets family of transcription factors.
    Yordy JS; Muise-Helmericks RC
    Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.
    Patton SE; Martin ML; Nelsen LL; Fang X; Mills GB; Bast RC; Ostrowski MC
    Cancer Res; 1998 May; 58(10):2253-9. PubMed ID: 9605774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
    Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter.
    Baker KM; Wei G; Schaffner AE; Ostrowski MC
    J Biol Chem; 2003 May; 278(20):17876-84. PubMed ID: 12637547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53.
    Iotsova V; Crépieux P; Montpellier C; Laudet V; Stehelin D
    Oncogene; 1996 Dec; 13(11):2331-7. PubMed ID: 8957074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
    Li R; Pei H; Watson DK; Papas TS
    Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models in the study of the Ets family of transcription factors.
    Bartel FO; Higuchi T; Spyropoulos DD
    Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
    Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
    Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
    Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
    Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR.
    Masselink H; Bernards R
    Oncogene; 2000 Mar; 19(12):1538-46. PubMed ID: 10734313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression.
    Wang Z; Wang DZ; Hockemeyer D; McAnally J; Nordheim A; Olson EN
    Nature; 2004 Mar; 428(6979):185-9. PubMed ID: 15014501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products.
    Chen L; Zhang W; Fregien N; Pierce M
    Oncogene; 1998 Oct; 17(16):2087-93. PubMed ID: 9798679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family.
    Schneikert J; Lutz Y; Wasylyk B
    Oncogene; 1992 Feb; 7(2):249-56. PubMed ID: 1549346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.
    Ladendorff NE; Wu S; Lipsick JS
    Oncogene; 2001 Jan; 20(1):125-32. PubMed ID: 11244510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism.
    McGhee L; Bryan J; Elliott L; Grimes HL; Kazanjian A; Davis JN; Meyers S
    J Cell Biochem; 2003 Aug; 89(5):1005-18. PubMed ID: 12874834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-step mechanism for recruitment of Pip by PU.1.
    Perkel JM; Atchison ML
    J Immunol; 1998 Jan; 160(1):241-52. PubMed ID: 9551977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
    Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of ETS genes induced by electromagnetic fields.
    Mucci N; Ianni A; Ursini CL; Arzani D; Bhat NK; Navarra P; Romano-Spica V
    In Vivo; 2001; 15(6):489-94. PubMed ID: 11887334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.